Atom | Addressing Unanswered Questions in Medicare Drug Price Negotiations

Due Dates: November 1, 2025 (anticipated, based on prior cycle)

Funding Amounts: $25,000 per award (three awards available); one-time payment; publication in JMCP

Summary: Competitive call for papers proposing innovative solutions to Medicare drug price negotiation challenges under the Inflation Reduction Act, with winning papers published in JMCP.

Key Information: Employees of pharmaceutical companies may submit but are not eligible for the monetary award.

Addressing Unanswered Questions in Medicare Drug Price Negotiations

Sign in to see full grant listing